News
Five burning questions on the FDA’s new Covid-19 vaccine framework
But the framework has perhaps created as much confusion as clarity. Broadly, the FDA said it will limit approval of Covid-19 vaccines to people 65 and older and to those at risk for severe Covid outcomes, and will require vaccine makers to conduct clinical trials investigating whether the shots benefit healthy adults and children.
Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of ...
"Again, I don't want to give advice," Kennedy said. "I can tell you, in Europe, they don't use the chickenpox vaccine ...
Amid a growing distrust of vaccines and the medical community, there’s also been a growing divide in the Make America Healthy ...
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...
South Korean vaccine company SK Bioscience said it has prevailed in a lawsuit brought by Pfizer that accused it of infringing on the patent for the drugmaker's Prevnar 13 vaccine.
FARGO — Adults should check their vaccination records, as ones born before 1989 may have only received one dose of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback